MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Association Between Depression and Sleep Disorders in Parkinson’s Disease

    J. Jiang, W. Wu, M. Mao (Suzhou, China)

    Objective: To investigate the clinical characteristics of depression in Parkinson’s disease (PD) and its correlation with sleep disorders. Background: PD is the second most common…
  • 2025 International Congress

    α-Synuclein Triggers Neuroinflammatory Damage through the suppression of MEF2C

    X. Liu, E. Tao (Shenzhen, China)

    Objective: To explore the effects of microglial myocyte enhancer factor 2C (MEF2C) in neuroinflammation induced by α-synuclein. Background: The abnormal aggregation of α-synuclein (α-syn) is a critical…
  • 2025 International Congress

    A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease

    D. Chouhan, A. Bello, K. Cullen, J. Duda (Philadelphia, USA)

    Objective: To create a three dimensional (3D) long-living model of human tissue-engineered nigrostriatal pathway (TE-NSP) comprised of discrete somatic and axonal compartments recapitulating the native…
  • 2025 International Congress

    Predictors of Рostural Instability and Gait Disturbances after STN-DBS in Parkinson’s Disease

    O. Alenikova, A. Chumak, L. Parhach, N. Alenikov (Minsk, Belarus)

    Objective: The aim was to identify characteristic pre-surgical visual and vestibular disturbances, as well as neuroimaging changes that could be predictors of PI and gait…
  • 2025 International Congress

    Differentiating Parkinsonism and related diseases by specific Parkinsonism patterns

    JX. Wang, B. Wang, XH. Chen, W. Luo (Hangzhou, China)

    Objective: This study aimed to identify characteristic parkinsonism patterns across PD, MSA and PSP, and evaluate their utility in early differentiation. Background: Parkinson's disease (PD), multiple…
  • 2025 International Congress

    Transcranial sonography in Parkinson’s disease patients

    D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To present the usage and results of transcranial sonography (TCS) in Parkinson's disease (PD) patients. Background: (TCS) has emerged as a valuable diagnostic tool…
  • 2025 International Congress

    Multiparametric Prediction of Mild Cognitive Impairment in Parkinson’s Disease Using a Combination of Structural and Functional MRI Measures

    G. Rathi, T. Davis, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)

    Objective: To investigate whether the multiparametric combination of structural and functional (fMRI) neuroimaging parameters improves the prediction of mild cognitive impairment (MCI) in Parkinson's disease…
  • 2025 International Congress

    Clinical And Cerebellar Structural Alterations In Parkinson’s Disease Patients With Freezing Of Gait

    E. Sarasso, A. Gardoni, A. Grassi, L. Zenere, S. Basaia, G. Bonardi, S. Carta, I. Di Vico, E. Mantovani, E. Canu, M. Bressan, V. Castelnovo, E. Sibilla, C. Tripodi, F. Freri, R. Balestrino, M. Trentinaglia, F. Maffei, V. Chiodega, S. Tamburin, MA. Volontè, S. Mariotto, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: To assess clinical and cerebellar volume differences in Parkinson’s disease (PD) patients with and without freezing of gait (PD-FoG and PD-NOFoG). Background: Cerebellum plays…
  • 2025 International Congress

    Novel Parkinson’s Disease Genetic Risk Factors Within and Across European Populations

    GP2. Parkinson'S_genetics_program (Bethesda, USA)

    Objective: To assess genome-wide genetic risk for Parkinson’s disease (PD) within and across genetically determined European ancestries (European, Ashkenazi Jewish, Finnish, and Icelandic). We conducted…
  • 2025 International Congress

    Analysis showed resemblance in Genetic architecture of rare movement disorders in consanguineous Pashtoon ethnic group

    S. Rehman (Bannu, Pakistan)

    Objective: Present Study was focused on improving the available genetic architecture of rare movement disorders (MD) and subsequent use of this knowledge for protective measurements…
  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley